Combined dimercaptosuccinic acid and zinc treatment in neurological Wilson’s disease patients with penicillamine-induced allergy or early neurological deterioration

The clinical data of safety and efficacy of a combined treatment with dimercaptosuccinic acid (DMSA) and Zinc with 2 years’ follow-up in 60 neurological Wilson’s disease (WD) patients was retrospectively analyzed. All the patients included in the present study were newly diagnosed and initialized wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xiao-Qun, Li, Liang-Yong, Yang, Wen-Ming, Wang, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2020
Materias:
Pharmacology & Toxicology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435022/
https://www.ncbi.nlm.nih.gov/pubmed/32809015
http://dx.doi.org/10.1042/BSR20200654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435022/
https://www.ncbi.nlm.nih.gov/pubmed/32809015
http://dx.doi.org/10.1042/BSR20200654

Ejemplares similares